Cargando…
lncRNA NORAD promotes lung cancer progression by competitively binding to miR-28-3p with E2F2
Lung cancer (LC) is a prevailing primary tumor in the lung. lncRNA non-coding RNA activated by DNA damage (NORAD) is a popular target in human cancers. This experiment is designed to probe the mechanism of lncRNA in LC progression. NORAD expression in normal lung epithelial cells and LC cells was ex...
Autores principales: | Mao, Wenjun, Wang, Shengfei, Chen, Ruo, He, Yijun, Lu, Rongguo, Zheng, Mingfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520332/ https://www.ncbi.nlm.nih.gov/pubmed/36245705 http://dx.doi.org/10.1515/med-2022-0538 |
Ejemplares similares
-
Erratum to “lncRNA NORAD promotes lung cancer progression by competitively binding to miR-28-3p with E2F2”
por: Mao, Wenjun, et al.
Publicado: (2022) -
Diagnostic implications of lncRNA NORAD in breast cancer
por: Zhang, Yaping, et al.
Publicado: (2023) -
LncRNA NORAD mediates KMT2D expression by targeting miR-204-5p and affects the growth of gastric cancer
por: Chen, Xinqi, et al.
Publicado: (2022) -
lncRNA NORAD Contributes to Colorectal Cancer Progression by Inhibition of miR-202-5p
por: Zhang, Jie, et al.
Publicado: (2018) -
lncRNA NORAD promotes the progression of osteosarcoma via targeting of miR-155-5p
por: Wang, Ye, et al.
Publicado: (2021)